CCO Neuroscience Podcast
Updates on new data and best practices in patient care across a wide variety of psychiatric and neurological illnesses from Clinical Care Options. Gain a deeper understanding and practical clinical insights on topics ranging from bipolar depression to Parkinson’s disease psychosis. Select episodes available for CME/CE credit.
- Update frequency
- every 24 days
- Average duration
- 26 minutes
- Episodes
- 39
- Years Active
- 2021 - 2025
Cognitive Conversations: Brain Health in Neurology
In this episode, Alireza Atri, MD, PhD, discusses his approach to patient conversations on brain health and provides advice to healthcare professionals practicing in community neurology settings, in …
Cognitive Conversations: Brain Health in Psychiatry
In this episode, dementia expert Anton Porsteinsson, MD, discusses his approach to conversations on brain health with patients and provides guidance for HCPs practicing in community psychiatry settin… |
Cognitive Conversations: Brain Health in Obstetrics and Gynecology
In this episode, Genevieve Neal-Perry, MD, PhD, discusses her approach to conversations on brain health with her patients in obstetrics and gynecology settings, in a dialogue with Robin Martinez, a p…
Cognitive Conversations: Brain Health in Primary Care
In this episode, Pierre N. Tariot, MD, discusses his approach to conversations on brain health with his patients and their family members in primary care settings, in a dialogue with Robin Martinez, …
Cognitive Conversations: Brain Health in Geriatric Practice
In this episode, Susan Scanland, MSN, CRNP, GNP-BC, CDP, discusses her approach to conversations on brain health with her patients and their family members in clinical practice as a gerontological nu…
Inpatient Treatment of Severe COVID-19 in Patients Who Are Immunocompromisedn People Who Are Immunocompromised
Listen in as Cristina Mussini, MD; Martin Witzenrath, MD, FERS; and Michele Bartoletti, MD, PhD, discuss best practices in managing people who are immunocompromised with COVID-19 in the hospital sett…
Reaching Patients Where They Are: Experience With LAI Antipsychotics in Community Practice
In this episode, Dr Robert Cotes and Dr David Goldsmith discuss their clinical experience with long-acting injectable antipsychotic treatments in the Grady Health System, with a focus on communicatio…
What’s New in the Treatment of Rett Syndrome?
In this episode, David N. Lieberman, MD, PhD, and Eric Marsh, MD, PhD, discuss recent updates relevant to the treatment of Rett syndrome, including:
- The recently updated Comprehensive Care Guidelines …
Assess the Efficacy and Safety of Emerging Strategies That Impact Brain Cholesterol Turnover
Link to CME: Claim Credit - https://bit.ly/3OByCaE
In this episode, Drs. Halford and Hahn discuss the current treatment landscape of developmental and epileptic encephalopathies (DEEs), such as Lennox…
Brain Cholesterol: The New Landscape of Neurological Disease Management
Link to CME: Claim Credit - https://bit.ly/3wbVkA1
In this episode, Drs. Halford and White discuss the emerging role of brain cholesterol in the development and potential treatment of neurological dis…
Defining Alzheimer’s Disease and MCI Management in the Modern Era
In this episode, Drs. Sabbagh and Isaacson discuss how to best approach Alzheimer’s disease (AD) and mild cognitive impairment (MCI) in clinical practice, including accurately diagnosing patients and…
Keeping Up With the Treatment Landscape for MDD
The treatment landscape of major depression is increasingly shifting from monoaminergic agents to agents that modulate glutamate and GABA. Healthcare professionals need to stay up to date and educate…
Rett Syndrome Tomorrow: Management Options on the Horizon
Rett syndrome is a rare but severe neurodevelopmental disorder, and current treatment approaches primarily focus on symptom management and supportive care. However, recent clinical developments are p…
Rett Syndrome Today: Current Options for Symptom Management
Rett syndrome affects many organ systems, and each patient has individual symptoms and experiences—there is no “one-size-fits-all” treatment approach. In this podcast episode, Rett syndrome experts D…
Rett Syndrome Today and Tomorrow: What Is Rett Syndrome?
In this podcast episode, experts in Rett syndrome, David N. Lieberman, MD, PhD, and Jeffrey Neul, MD, PhD, provide a comprehensive overview of Rett syndrome (RTT), a rare but severe neurodevelopmenta…
Long-term Solutions for Long-term Diseases: Using Long-Acting Injectable Antipsychotics in Practice
In this podcast episode, Leslie Citrome, MD, MPH, and Adam Lowy, MD, share a wealth of knowledge about long-acting injectable (LAI) antipsychotics. Their conversation begins with an overview of the p…
To the Rescue: Incorporating Rescue Medications Into Epilepsy Treatment Plans
In this podcast episode, epileptologists Aatif Husain, MD, and John Stern, MD, have a conversation about rescue therapies and how they fit into the spectrum of epilepsy management. Their discussion b…
Halting Hallucinations: A Discussion of Management Strategies for Parkinson’s Disease Psychosis
In this podcast episode, Marwan Sabbagh, MD, FAAN, and Marta San Luciano, MD, MS, FAAN, have a conversation about Parkinson’s disease psychosis (PDP). Their discussion provides information on the dis…
Tardive Dyskinesia Etiology: Risks and Considerations
In this episode, Christoph U. Correll, MD, and John M. Kane, MD, discuss the various etiologies of tardive dyskinesia (TD). Although most healthcare professionals are aware of the risk for TD that co…
Bipolar Disorder Research to Look For in 2023
In this episode, Greg W. Mattingly, MD, and Vladimir Maletic, MD, have a conversation about the ongoing bipolar disorder research and developments expected to have an impact in the coming year. They …